ORKA earnings: next report 2026-08-10, real EPS beat/miss history, analyst consensus Buy, P/E -38.72. Updated 2026-07-23.
Oruka Therapeutics (ORKA) Research Hub
Oruka Therapeutics (ORKA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 92.38 USD (+0.96%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -38.72, market cap 3.49B. This hub links to the full technical, earnings and options research available for ORKA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 92.38 USD (+0.96%) |
| 52-week range | 67.72 USD – 115.52 USD |
| Trend regime | Range |
| 14-day RSI | 42.8 (Bearish) |
| Trailing P/E | -38.72 |
| Market cap | 3.49B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for ORKA
Covered Call on ORKA: how it works, illustrative setup around the real 92.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ORKA: how it works, illustrative setup around the real 92.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ORKA: how it works, illustrative setup around the real 92.38 USD price, max profit/loss, breakeven and when to use it. Educational.
ORKA technical analysis: range, last 92.38 USD, RSI 42.8, 52w range 67.72 USD–115.52 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ORKA in?
Oruka Therapeutics (ORKA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ORKA in an uptrend or downtrend?
As of 2026-09-11, ORKA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ORKA's trailing P/E ratio?
ORKA's trailing P/E is -38.72, with a market cap of 3.49B. See the earnings research page for full valuation detail.
When does ORKA next report earnings?
ORKA is next scheduled to report earnings on 2026-08-10, with a consensus EPS estimate of -0.49 USD.